Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)

Samankaltaisia teoksia

• Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
  Tekijä: Paz-Ares, Luis, et al.
  Julkaistu: (2011)
• Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC
  Tekijä: Paz-Ares, Luis, et al.
  Julkaistu: (2014)
• Cover (EMBO Mol. Med. 7/2013)
  Julkaistu: (2013)
• Masthead (EMBO Mol. Med. 7/2013)
  Julkaistu: (2013)
• Masthead (EMBO Mol. Med. 9/2013)
  Julkaistu: (2013)